Enanta Pharmaceuticals, Inc.
← Back to ENTA Overview

Enanta Pharmaceuticals, Inc. (ENTA)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-7.06

Financial Fundamentals

ENTA • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2011-09-30-13.80
2011-12-31-17.42
2012-03-311.51
2012-06-30-13.86
2012-09-30-11.98
2012-12-312.21
2013-03-31-15.02
2013-06-30-11.81
2013-09-30-13.60
2013-12-31-22.73
2014-03-31-35.27
2014-06-303.99
2014-09-30-36.47
2014-12-315.63
2015-03-314.97
2015-06-3086.97
2015-09-3029.09
2015-12-315.92
2016-03-31-81.58
2016-06-30-97.25
2016-09-30-70.28
2016-12-31-32.02
2017-03-31-27.20
2017-06-30-20.37
2017-09-306.12
2017-12-3124.00
2018-03-3130.94
2018-06-3027.57
2018-09-3014.86
2018-12-3113.22
2019-03-31111.68
2019-06-3060.14
2019-09-3032.17
2019-12-3122.69
2020-03-31-42.66
2020-06-30-17.62
2020-09-30-7.83
2020-12-31-25.39
2021-03-31-11.28
2021-06-30-9.25
2021-09-30-11.65
2021-12-31-12.66
2022-03-31-10.89
2022-06-30-7.72
2022-09-30-10.14
2022-12-31-8.35
2023-03-31-5.65
2023-06-30-2.88
2023-09-30-2.09
2023-12-31-1.49
2024-03-31-2.89
2024-06-30-3.05
2024-09-30-1.90
2024-12-31-1.37
2025-03-31-1.30
2025-06-30-2.21
2025-09-30-3.42
2025-12-31-7.06

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.